Evidence map›Paper›PMID 42119389›Full record

ArticleCell calcium2026

Pseudomonas aeruginosa 3-oxo-C12HSL-induced apoptosis involves bitter taste receptor T2R14 and the mitochondrial calcium uniporter.

Zoey A Miller, Arielle Mueller, Joel C Thompson, Jordan S Williams, April Park, Nabil F Darwich, Yobouet Ines Kouakou, Sarah M Sywanycz, Brianna L Buchler, Nithin D Adappa and 4 more

Abstract read
In one paragraph

Article in Cell calcium, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

  • Update of
    2024
5 · Who and what money

Authors and funding

14 authors.

Zoey A MillerDepartment of Otorhinolaryngology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA; Pharmacology Graduate Group, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA. Electronic address: zoeym@pennmedicine.upenn.edu.
Arielle MuellerDepartment of Otorhinolaryngology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Joel C ThompsonDepartment of Otorhinolaryngology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Jordan S WilliamsDepartment of Otorhinolaryngology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA; Pharmacology Graduate Group, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
April ParkDepartment of Otorhinolaryngology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Nabil F DarwichDepartment of Otorhinolaryngology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Yobouet Ines KouakouDepartment of Otorhinolaryngology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Sarah M SywanyczDepartment of Otorhinolaryngology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Brianna L BuchlerDepartment of Otorhinolaryngology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Nithin D AdappaDepartment of Otorhinolaryngology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
James N PalmerDepartment of Otorhinolaryngology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Noam A CohenDepartment of Otorhinolaryngology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA; Corporal Michael J. Crescenz Philadelphia VA Medical Center, USA; Monell Chemical Senses Center, USA.
Ryan M CareyDepartment of Otorhinolaryngology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Robert J LeeDepartment of Otorhinolaryngology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA; Department of Physiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA. Electronic address: rjl@pennmedicine.upenn.edu.

Funding

Immune function of bitter taste receptors in human macrophagesR01AI167971 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI Nithin Adappa, Robert J. Lee · 2022 to 2026
$2.5M
Intracellular signaling in airway solitary chemosensory (tuft) cellsR01HL168060 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI Robert J. Lee · 2024 to 2026
$1.4M
Predoctoral Training Grant in PharmacologyT32GM154643 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI Julie A Blendy · 2025 to 2026
$1.1M
Bitter taste receptors in oral cancer tumor-associated macrophagesR01DE034474 · NIDCR · UNIVERSITY OF PENNSYLVANIA · PI Ryan Michael Carey · 2025 to 2026
$1.0M
Development and validation of novel optical methods for direct screening of taste receptor activationR21DC020041 · NIDCD · UNIVERSITY OF PENNSYLVANIA · PI LEE, ROBERT J. · 2023 to 2024
$447k
NHLBI NIH HHS R01 HL168060NIAID NIH HHS R01 AI167971NIDCD NIH HHS R21 DC020041NIDCR NIH HHS R01 DE034474NIGMS NIH HHS T32 GM154643
6 · The paper itself

Abstract

Pseudomonas aeruginosa is an opportunistic pathogen that infects immunocompromised patients. P. aeruginosa infects airways in cystic fibrosis (CF) and chronic rhinosinusitis (CRS) and also infects oral and nasal epithelia in immunocompromised head and neck squamous cell carcinoma patients. P. aeruginosa produces several apoptosis-inducing factors, including N-3-oxo-dodecanoyl-L-homoserine lactone (3-oxo-C12HSL). Additionally, 3-oxo-C12HSL activates several human bitter taste G protein-coupled receptors (taste family 2 receptors, or T2Rs), including T2R14 expressed throughout the body. We previously discovered that activation of T2R14 causes apoptosis in either HNSCC cells or primary nasal cells cultured to reflect a squamous phenotype. While the conducting airways are normally a pseudostratified columnar epithelium, epithelial de-differentiation, squamous metaplasia, and enhanced apoptosis occur in both CF and CRS airways, often correlating with sites of P. aeruginosa colonization. We hypothesized that 3-oxo-C12HSL-induced apoptosis may involve T2R14. We found that 3-oxo-C12HSL activates sustained intracellular Ca

Indexed as

4-ButyrolactoneApoptosisCalcium ChannelsHomoserinePseudomonas aeruginosaReceptors, G-Protein-CoupledCalciumHumansMitochondriaTaste Receptors, Type 24-ButyrolactoneCalciumCalcium ChannelsHomoserinemitochondrial calcium uniporterN-(3-oxododecanoyl)homoserine lactoneReceptors, G-Protein-CoupledTaste Receptors, Type 2Chronic rhinosinusitisCystic fibrosisHead and neck squamous cell carcinomaIntrinsic apoptosisReactive oxygen speciesSquamous metaplasia

Identifiers

PMID42119389
PMCPMC13688700

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.